A practical guide to pharmacological biotechnology / (Record no. 4229)

MARC details
000 -LEADER
fixed length control field 05368cam a2200781 i 4500
001 - CONTROL NUMBER
control field on1080548053
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240228144917.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200109s2019 si ac b 000 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2019933573
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 101760581
Source DNLM
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9789811363542
Qualifying information
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9811363544
Qualifying information
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9789811363559
Qualifying information
029 0# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier NLM
System control number 101760581
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1080548053
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Description conventions rda
Transcribing agency NLM
Modifying agency OCLCO
-- OCLCA
-- UKQUB
-- OCLCO
-- OCLCF
-- S2H
-- YDX
-- OCLCO
-- SBI
042 ## - AUTHENTICATION CODE
Authentication code pcc
049 ## - LOCAL HOLDINGS (OCLC)
Holding library SBIM
050 ## - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS380.P314.P733 2019
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Patra, Jayanta Kumar,
Relator term
9 (RLIN) 1031
245 12 - TITLE STATEMENT
Title A practical guide to pharmacological biotechnology /
Statement of responsibility, etc. Jayanta Kumar Patra, Swagat Kumar Das, Gitishree Das, Hrudayanath Thatoi.
Medium [print]
260 #1 - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Singapore :
Name of publisher, distributor, etc. Springer,
Date of publication, distribution, etc. (c)2019.
300 ## - PHYSICAL DESCRIPTION
Extent xiii, 142 pages :
Other physical details illustrations ;
Dimensions 24 cm.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term unmediated
Media type code n
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term volume
Carrier type code nc
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Learning materials in biosciences,
ISBN 2509-6125
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note PART 1.
505 0# - FORMATTED CONTENTS NOTE
Title Introduction --
-- 1.1 Rules of laboratory safety in a pharmacology laboratory --
-- 1.2 Commom instruments and their uses used in a pharmacology laboratory
505 0# - FORMATTED CONTENTS NOTE
Miscellaneous information _______________________________________________
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note PART 2.
505 0# - FORMATTED CONTENTS NOTE
Title General aspects of Pharmacology laboratory --
-- 2.1 Safety and Risk assessment --
-- 2.2 Use and Handling of laboratory animals --
-- 2.3 Experimental design --
-- 2.4 Essential statistics --
-- 2.5 Cumulative Dose Response Curve --
-- 2.6 Toxicology --
-- 2.7 Basic instruments and techniques in Pharmacology Laboratory
505 0# - FORMATTED CONTENTS NOTE
Miscellaneous information _______________________________________________
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note PART 3.
505 0# - FORMATTED CONTENTS NOTE
Title Isolated tissues and organs --
-- 3.1 Basic instruments used for isolated tissue experiments --
-- 3.2 Organ baths --
-- 3.3 Smooth muscle preparations --
-- 3.4 Skeletal muscle preparations --
-- 3.5 Cardiac muscle preparations
505 0# - FORMATTED CONTENTS NOTE
Miscellaneous information _______________________________________________
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note PART 4.
505 0# - FORMATTED CONTENTS NOTE
Title Isolated tissues for screening of drugs --
-- 4.1 Evaluation of antidiabetic agents --
-- 4.2 Evaluation of antidepressants --
-- 4.3 Evaluation of antihypertensive agents --
-- 4.4 Evaluation of antiulcer agents --
-- 4.5 Evaluation of hepatotoxicity --
-- 4.6 Evaluation of Antioxidant agents --
-- 4.7 Evaluation of local anaesthetics
505 0# - FORMATTED CONTENTS NOTE
Miscellaneous information _______________________________________________
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note PART 5.
505 0# - FORMATTED CONTENTS NOTE
Title Genotoxicity and Toxicological studies --
-- 5.1 The Mouse Lymphoma Assay --
-- 5.2 The Comet Assay --
-- 5.3 In vitro Genotoxicity assay --
-- 5.4 In vitro Teratogenicity Testing --
-- 5.5 Histopathological studies of animal tissues --
-- 5.6 Drug poisoning
505 0# - FORMATTED CONTENTS NOTE
Miscellaneous information _______________________________________________
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note PART 6.
505 0# - FORMATTED CONTENTS NOTE
Title Experimental Animal studies --
-- 6.1 Pyrogen testing --
-- 6.2 Collecting blood from mice --
-- 6.3 Studies on different parameters of blood --
-- 6.4 Experiment on central nervous system --
-- 6.5 Evaluation on cardiovascular system --
-- 6.6 Experiments on GI tract
505 0# - FORMATTED CONTENTS NOTE
Miscellaneous information _______________________________________________
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note PART 7.Clinical trials --
Title 7.1 Clinical Pharmacology and its genesis --
-- 7.2 National and International agencies and their role in Clinical pharmacology --
-- 7.3 Stages in drug development and clinical trials --
-- 7.4 Ethics in Clinical research --
-- 7.5 Safety assessment in Clinical trials
505 0# - FORMATTED CONTENTS NOTE
Miscellaneous information _______________________________________________
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note PART 8.
505 0# - FORMATTED CONTENTS NOTE
Title IPR and ethics in animal studies --
-- 8.1 Intellectual property rights and its different categories --
-- 8.2 Importance of IPR in drug development --
-- 8.3 Patenting cells, cell lines and animals --
-- 8.4 Ethics in laboratory animal studies --
-- 8.5 Risk assessment and management --
-- 8.6 Good laboratory practices.
520 ## - SUMMARY, ETC.
Summary, etc. Pharmacological biotechnology is applied to and used to study drug development, working mechanisms, diagnosis, and therapies. This manual is the textbook covering the whole range of experiments related to pharmacology. It also contains basic laboratory safety guidelines along with the basic calculations and formulas used in a laboratory. Each chapter starts with an introduction/theory into the basic approach followed by detailed methods sections with easy-to-follow protocols and comprehensive troubleshooting, calculations and possible questions for examination. The target group is researchers who are studying pharmacological biotechnology in the laboratory.
530 ## - COPYRIGHT INFORMATION:
COPYRIGHT INFORMATION COPYRIGHT NOT covered - Click this link to request copyright permission:
Uniform Resource Identifier <a href="b">b</a>
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biopharmaceutics.
9 (RLIN) 1032
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Medical laboratories.
9 (RLIN) 1033
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmaceutical biotechnology.
9 (RLIN) 1034
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmaceutical technology.
9 (RLIN) 1035
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology.
9 (RLIN) 1036
655 #0 - INDEX TERM--GENRE/FORM
Genre/form data or focus term BioMed
655 #0 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Nursing
9 (RLIN) 347
655 #0 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Theology & Religion
9 (RLIN) 312
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Das, Gitishree,
Relator term
9 (RLIN) 1037
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Das, Swagat Kumar,
Relator term
9 (RLIN) 1038
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thatoi, H. N.,
Relator term
9 (RLIN) 1039
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Learning materials in biosciences.
International Standard Serial Number 2509-6133
9 (RLIN) 909
902 ## - LOCAL DATA ELEMENT B, LDB (RLIN)
c 1
d CYNTHIA SNELL
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Nursing-Reference (LIBRARY USE ONLY)
VENDOR
Classification part RS
Delivery Date: ACADEMIC YEAR - ie 2022-2023 2021-2022
COST 106.79
PUBLICATION YEAR 2019
print -BUDGET LINE 10-1411-7022-? NURS
REQUESTED BY: NURSING DEPARTMENT
INVOICE NUMBER: 349620
Source of classification or shelving scheme
REPLACEMENT COST (GET FROM AMAZON) 90.00
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Cost, normal purchase price Total Checkouts Full call number Barcode Date last seen Cost, replacement price Price effective from Koha item type
        G. Allen Fleece Library G. Allen Fleece Library Reference (1st floor - front of library) 05/01/2022   106.79   RS380.P314.P733 2019 31923002064570 01/25/2024 90.00 07/24/2022 Nursing-Reference (LIBRARY USE ONLY)

Powered by Koha